Regend – Health Startup – China

What if damaged lungs could heal from within?  Every year, millions of people lose the ability to breathe freely.

Regend Therapeutics, a biotech startup from China, is trying to change that.

The company developed a method that uses a patient's own cells to regenerate lung tissue destroyed by chronic disease. In clinical trials, patients who could barely walk returned to daily life.

Their IP spans three continents, supporting a treatment that seeks to reimagine the future of respiratory medicine.